These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9276519)

  • 1. Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites.
    Tomioka H; Sato K; Sano C; Akaki T; Shimizu T; Kajitani H; Saito H
    Clin Exp Immunol; 1997 Aug; 109(2):248-54. PubMed ID: 9276519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids.
    Akaki T; Sato K; Shimizu T; Sano C; Kajitani H; Dekio S; Tomioka H
    J Leukoc Biol; 1997 Dec; 62(6):795-804. PubMed ID: 9400821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis.
    Akaki T; Tomioka H; Shimizu T; Dekio S; Sato K
    Clin Exp Immunol; 2000 Aug; 121(2):302-10. PubMed ID: 10931146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nontuberculous mycobacteriosis; the present status and in the future. Mechanisms of host resistance to Mycobacterium avium complex and Mycobacterium tuberculosis infection].
    Tomioka H; Sato K; Shimizu T; Akaki T
    Kekkaku; 1998 Feb; 73(2):71-6. PubMed ID: 9545699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages.
    Sano K; Tomioka H; Sato K; Sano C; Kawauchi H; Cai S; Shimizu T
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2132-9. PubMed ID: 15155211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel type of antimicrobial mechanism in host macrophages against mycobacterial infections].
    Shimizu T; Tomioka H
    Nihon Hansenbyo Gakkai Zasshi; 2009 Sep; 78(3):283-91. PubMed ID: 19803380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative profiles of intramacrophage behavior of Mycobacterium tuberculosis and Mycobacterium avium complex with different levels of virulence.
    Sano K; Sato K; Sano C; Shimizu T; Tomioka H
    Microbiol Immunol; 2002; 46(7):483-6. PubMed ID: 12222934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of picolinic acid on the antimicrobial functions of host macrophages against Mycobacterium avium complex.
    Tomioka H; Shimizu T; Tatano Y
    Int J Antimicrob Agents; 2007 Apr; 29(4):460-4. PubMed ID: 17296287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.
    Sarmento A; Appelberg R
    Infect Immun; 1996 Aug; 64(8):3224-30. PubMed ID: 8757857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    Denis M
    J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).
    Sato K; Akaki T; Tomioka H
    Clin Exp Immunol; 1998 Apr; 112(1):63-8. PubMed ID: 9566791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
    Chan J; Xing Y; Magliozzo RS; Bloom BR
    J Exp Med; 1992 Apr; 175(4):1111-22. PubMed ID: 1552282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T cell proliferation.
    Maw WW; Shimizu T; Sato K; Tomioka H
    Clin Exp Immunol; 1997 Apr; 108(1):26-33. PubMed ID: 9097907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor.
    Keller R; Keist R; Wechsler A; Leist TP; van der Meide PH
    Int J Cancer; 1990 Oct; 46(4):682-6. PubMed ID: 2120138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
    Shimizu T; Tomioka H; Sato K; Sano C; Akaki T; Dekio S; Yamada Y; Kamei T; Shibata H; Higashi N
    Antimicrob Agents Chemother; 1999 Mar; 43(3):514-9. PubMed ID: 10049260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells.
    Sato K; Tomioka H
    J Antimicrob Chemother; 1999 Mar; 43(3):351-7. PubMed ID: 10223590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide.
    Tohyama M; Kawakami K; Futenma M; Saito A
    Clin Exp Immunol; 1996 Mar; 103(3):436-41. PubMed ID: 8608643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-Mycobacterium intracellulare complex infection induced by IFN-gamma is mediated by TNF-alpha.
    Gomez-Flores R; Tucker SD; Kansal R; Tamez-Guerra R; Mehta RT
    J Antimicrob Chemother; 1997 Feb; 39(2):189-97. PubMed ID: 9069539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.
    Brennan RE; Russell K; Zhang G; Samuel JE
    Infect Immun; 2004 Nov; 72(11):6666-75. PubMed ID: 15501800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of a novel antioxidant gene from Mycobacterium avium against nitrosative and oxidative stress in E. coli.
    He S; Wang A; Ning X; Yang D; Ling M
    World J Microbiol Biotechnol; 2017 Jun; 33(6):127. PubMed ID: 28547728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.